Non-uniform granule size during wet granulation – inspection-ready justification


Published on 20/01/2026

Addressing Non-uniform Granule Size in Wet Granulation for Improved Manufacturing Excellence

In the realm of pharmaceutical manufacturing, consistency in granule size during the wet granulation process is paramount for achieving optimal product quality and yield. Non-uniform granule size can lead to a range of issues, including variability in drug release profiles, alterations in tableting and packaging efficiency, and ultimately, compliance risks. This article seeks to provide a structured approach to identifying, investigating, and rectifying the problem of non-uniform granule size while ensuring compliance with regulatory standards.

For a broader overview and preventive tips, explore our Granulation Process Optimization.

By the end of this article, readers will have the frameworks and actionable strategies necessary to effectively address granulation size variability, enhance manufacturing processes, and remain inspection-ready for FDA, EMA, and MHRA audits.

Symptoms/Signals on the Floor or in the Lab

The first indication of non-uniform granule size typically arises during the visual inspection or physical characterization of the granules. Here are some common symptoms observed:

  • Inconsistent
Flow Properties: Difficulty in transferring granules from one processing step to the next may indicate size variability.
  • Tablet Weight Variability: Increasing variation in tablet weights can suggest that granule homogeneity is affected.
  • Changes in Dissolution Profiles: Altered release characteristics in stability or dissolution testing may signify a granule size issue.
  • ABC (Agglomeration, Blending, Compaction): Variability in parameters such as blend uniformity and compaction pressure can emerge as a signal of inconsistent granule sizes.
  • Likely Causes

    The non-uniformity of granule size can stem from various factors categorized into six main areas: Materials, Method, Machine, Man, Measurement, and Environment.

    Materials

    Subpar excipients or API characteristics can lead to inconsistency in granule formation. Variability in particle size of raw materials or moisture levels can prevent even granulation.

    Method

    Inadequate granulation methodology, such as inappropriate binder concentration or incorrect granulation time, can lead to non-uniform granules.

    Machine

    Equipment malfunctions or suboptimal settings on granulators, such as impeller speeds and the intensity of liquid addition can impact granule size distribution.

    Man

    Operator errors during manual handling or failure to follow SOPs (Standard Operating Procedures) can introduce variability in the process.

    Measurement

    Inaccurate measurement methods for assessing granule size can lead to misinterpretation of the granulation state, masking the problem of non-uniformity.

    Environment

    Fluctuating temperature and humidity levels in the manufacturing area can significantly affect granule formation, leading to yield discrepancies.

    Immediate Containment Actions

    In the event of detecting non-uniform granule size, immediate containment actions should be executed preferably within the first 60 minutes:

    1. Cease production: Stop the granulation process to prevent further issues while the problem is being assessed.
    2. Isolate affected batches: Quarantine any currently processed batches to prevent release.
    3. Conduct a rapid assessment: Perform a quick evaluation of the granule size distributions using available methods (e.g., sieve analysis or laser diffraction).
    4. Document findings: Maintain detailed records of observations and initial assessments for future investigations.

    Investigation Workflow

    Building a comprehensive investigation workflow is essential to understand the underlying causes of non-uniform granule size:

    1. Data Collection: Gather data on all aspects of the granulation process including SOP adherence, material specifications, machine settings, and environmental conditions.
    2. Granule Size Analysis: Utilize different analytical techniques such as microscopy, laser diffraction, or dynamic image analysis for precise measurement of granule size distribution.
    3. Trend Analysis: Assess performance trends in granule size over time to identify patterns related to specific batches or times.
    4. Review of Historical Data: Investigate data from prior production runs for similar conditions or deviations that occurred.

    Root Cause Tools

    Employing systematic tools for root cause analysis can help pinpoint the specific sources of non-uniform granulation:

    5-Why Analysis

    Ideal for diving into the layers of an issue through a straightforward questioning process: ask “Why” up to five times until the root cause is uncovered.

    Fishbone Diagram

    This tool helps visualize potential causes of a problem categorized by the aforementioned causes (Materials, Method, Machine, etc.), which can facilitate brainstorming during team discussions.

    Related Reads

    Fault Tree Analysis

    Used in cases of complex failures involving multiple systems or variables, it allows for a detailed exploration of how certain failures can lead to the overarching problem.

    CAPA Strategy

    A robust Corrective and Preventive Action (CAPA) strategy must address the problem effectively:

    Correction

    Implement immediate corrective actions which could include adjusting the granulation parameters or equipment maintenance based on initial findings.

    Corrective Action

    Develop action plans that address identified root causes to prevent recurrence. This may involve revising training programs, updating SOPs, or replacing faulty equipment.

    Preventive Action

    Long-term strategies might include establishing better monitoring of process parameters, additional training for personnel, and routine maintenance schedules for equipment.

    Control Strategy & Monitoring

    The development of a robust control strategy is essential for ongoing monitoring and future risk mitigation:

    • Statistical Process Control (SPC): Implement SPC to analyze variations in granule size and utilize control charts to monitor process stability.
    • Regular Sampling: Schedule regular sampling of granules at different processing stages to catch variability early.
    • Alarms and Notifications: Utilize equipment alarms to alert operators to deviations in metabolic parameters, ensuring immediate intervention if necessary.
    • Verification: Confirm through in-process checks that granule sizes remain within specified ranges throughout production.

    Validation / Re-qualification / Change Control Impact

    When addressing non-uniform granule size, the implications for validation and other regulatory-related activities must be assessed carefully:

    • Validation: Validate all changes made to the granulation process to ensure they yield consistent results. This may include revalidation of analytical methods used for size distribution assessment.
    • Re-qualification: Re-qualify equipment if changes made affect how granulation is performed or if maintenance was required.
    • Change Control: Establish a change control process to document and evaluate any modifications made to ensure compliance with relevant regulations.

    Inspection Readiness: What Evidence to Show

    To ensure compliance during inspections, it is vital to have comprehensive documentation ready:

    • Records: Maintain clean and thorough records of all production processes, batch production records, and analytical testing data related to granulation size.
    • Logs: Keep detailed equipment logs to document all maintenance and calibrations performed on granulation machinery.
    • Batch Documents: Ensure batch records include granule size data and any deviations or non-conformances noted during the batch process.
    • Deviations: Document any deviations in granule size and the corresponding CAPA taken to manage them.

    FAQs

    What is the significance of uniform granule size in wet granulation?

    Uniform granule size is crucial for ensuring consistent tablet weight and dissolution profiles, which impacts product quality and regulatory compliance.

    How can non-uniform granule size affect product quality?

    It can lead to variations in drug release rates, decreased efficacy, and potential product recalls, which can jeopardize patient safety.

    What instruments can be used to measure granule size?

    Common instruments include sieves, laser diffraction instruments, and dynamic image analyzers.

    How often should process parameters be monitored?

    Regular monitoring should be ongoing, with specific checkpoints during critical production stages documented in real-time.

    What are some common causes of granule size variability?

    Causes can include inconsistent raw materials, equipment malfunction, improper granulation techniques, and environmental fluctuations.

    What approach should be taken for operator training?

    Operators should be trained regularly on SOPs, equipment handling, and granulation principles to minimize human error.

    How important is documentation during an investigation?

    Thorough documentation is critical for tracing the steps taken during an investigation and substantiating any corrective actions implemented.

    What role does regulatory compliance play in granulation?

    Regulatory compliance ensures that all manufacturing processes, including granulation, meet established quality standards, thereby safeguarding public health.

    Pharma Tip:  Binder distribution variability during wet granulation – GMP-compliant optimization approach